The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Underw Regulatory News (HUW)

Share Price Information for Helios Underw (HUW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 165.00
Bid: 160.00
Ask: 170.00
Change: -5.00 (-2.94%)
Spread: 10.00 (6.25%)
Open: 170.00
High: 170.00
Low: 165.00
Prev. Close: 170.00
HUW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Revision to Adjusted Net Asset Value

16 Feb 2021 13:37

RNS Number : 2820P
Helios Underwriting Plc
16 February 2021
 

 

Helios Underwriting plc

("Helios", "Company" or the "Group")

 

Revision to Adjusted Net Asset Value

 

Helios, the unique investment vehicle which acquires and consolidates underwriting capacity at Lloyd's, announces an update on the Company's approach to determining the adjusted net asset value of the Company.

 

Adjusted net asset value

Helios has disclosed an adjusted net asset value to allow investors to assess the value of the underlying assets in the business. Two adjustments have been made to the net asset value as disclosed in the Company's historic consolidated balance sheets to arrive at an adjusted net asset value. The net asset value as disclosed in the Company's audited financial statements remains unaffected.

 

a) In the consolidated balance sheets, the value of the capacity was included at "Fair Value", being that value at the time it was acquired with an LLV, as adjusted for any impairment. A management adjustment was made to include in the adjusted net asset value the current value of the capacity as determined by reference to the weighted average prices from the last Lloyd's capacity auctions. This increased the value of capacity as at 30th June 2020 from £21.6m to £26.8m. This correctly reflected the value of the capacity portfolio.

b) A second management adjustment was made to include Group letters of credit relating to reinsurance policies of LLVs that has been acquired in the past. As at 30th June 2020, the value of these Group letters of credit was £2.9m. These reinsurance policies provide third party funds at Lloyd's ("FAL") for certain LLVs which, as off-balance sheet items, are not included on the balance sheets of LLVs. On acquisition of these LLVs, an assessment of the Fair Value of the assets acquired was made, including the assets provided by these reinsurance policies and a reserve at consolidation level was made to reflect the value of the third party FAL provided. Following an internal review, the further management adjustment to reflect the value of these assets was unnecessary as the provision on consolidation properly reflected the value of the Group letters of credit and consequently the adjusted net asset value per share was overstated.

 

The Board will be considering adopting an accounting policy to value assets at current fair value rather than using cost at the time of acquisition for both the capacity value and for the value of the Group letters of credit.

 

The table below shows the change to the calculation of the adjusted net asset value per share reflecting the capital raise as completed in November 2020, excluding the adjustment for the Group letters of credit.

 

 

As at

Jun 2020

Equity Raise (Nov 2020)

Pro forma Nov 2020

 

£'000's

£'000's

£'000's

Net tangible assets

6,397

13,268

19,665

Value of capacity (WAV)

 26,827

 

 30,826

Adjusted Net assets

33,224

 

50,491

 

 

 

 

Fully diluted share in issue, thousands

17,978

15,534

33,512

Revised ANAV per share, £

1.85

 

1.51

Latest published ANAV* fully diluted, £

2.01

 

1.55

Reduction

8.1%

 

3.0%

 

*As announced on 2 November 2020 and adjusted for the Company's Joint Share Ownership Plan shares nearing vesting, but before the effect of the weighted average price from the Lloyd's capacity auctions which was made available at the end of November 2020 and any subsequent acquisition of capacity.

 

Notes to the adjustments:

a) The capital raise in November 2020, approximately 15.288 million new ordinary shares were issued increasing shareholders' funds (net of costs) by approximately £18.0m. The increase in net tangible assets (excluding the value of capacity acquired with LLVs that were satisfied by the issue of new ordinary shares) was approximately £13.268m.

b) The value of the capacity portfolio as at 31st December 2020 reflecting the weighted average prices as at 4th quarter 2020 and the enlarged capacity portfolio has been included.

 

 

For further information please contact:

 

Helios Underwriting plc

Nigel Hanbury - Chief Executive +44 (0)7787 530 404 / nigel.hanbury@huwplc.com

Arthur Manners - Chief Financial Officer +44 (0)7754 965 917

 

Shore Capital (Nomad and Broker)

Robert Finlay +44 (0)20 7408 4080

David Coaten

Henry Willcocks

 

Willis Re Securities (Financial Adviser)

Alastair Rodger +44 (0)20 3124 6033

Quentin Perrot +44 (0)20 3124 6499

 

Buchanan

Helen Tarbet / Henry Wilson / George Beale +44 (0)7872 604 453

+44 (0)20 7466 5111 

 

About Helios

Helios provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market writing approximately £110m of capacity for the 2021 account. The portfolio provides a good spread of business being concentrated in property insurance and reinsurance. For further information please visit www.huwplc.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVBXGDDUXBDGBL
Date   Source Headline
22nd Apr 20247:00 amRNSDirectorate Change
25th Mar 20242:53 pmRNSChange of Registered Office
22nd Mar 20247:00 amRNSNAV Update - 31 December 2023
4th Mar 20247:00 amRNSHelios appoints Adhiraj Maitra as COO
1st Feb 20247:00 amRNSTotal Voting Rights
26th Jan 20247:00 amRNSTransaction in Own Shares
25th Jan 20247:00 amRNSTransaction in Own Shares
24th Jan 20247:00 amRNSTransaction in Own Shares
23rd Jan 20247:00 amRNSTransaction in Own Shares
22nd Jan 20247:00 amRNSTransaction in Own Shares
12th Jan 20247:00 amRNSTransaction in Own Shares
11th Jan 20247:00 amRNSTransaction in Own Shares
10th Jan 20247:00 amRNSTransaction in Own Shares
8th Jan 20247:00 amRNSTransaction in Own Shares
4th Jan 20247:00 amRNSTransaction in Own Shares
3rd Jan 20247:00 amRNSTransaction in Own Shares
2nd Jan 20247:00 amRNSTotal Voting Rights
29th Dec 20237:00 amRNSTransaction in Own Shares
28th Dec 20237:00 amRNSTransaction in Own Shares
27th Dec 20237:00 amRNSTransaction in Own Shares
22nd Dec 20237:00 amRNSTransaction in Own Shares
21st Dec 20237:00 amRNSTransaction in Own Shares
20th Dec 20237:00 amRNSTransaction in Own Shares
18th Dec 20234:31 pmRNSShare Repurchase Programme
15th Dec 20237:30 amRNSHelios grows 2024 portfolio to over £500m capacity
11th Dec 202310:03 amRNSTransaction in Own Shares
11th Dec 20239:59 amRNSTransaction in Own Shares
11th Dec 20237:00 amRNSNet Asset Value as at 30 September 2023
7th Dec 20237:00 amRNSTransaction in Own Shares
6th Dec 20237:00 amRNSTransaction in Own Shares
5th Dec 20237:00 amRNSTransaction in Own Shares
4th Dec 20237:00 amRNSTransaction in Own Shares
1st Dec 20237:01 amRNSTransaction in Own Shares
1st Dec 20237:00 amRNSTotal Voting Rights
30th Nov 20237:44 amRNSTransaction in Own Shares
29th Nov 20237:00 amRNSTransaction in Own Shares
28th Nov 20237:00 amRNSTransaction in Own Shares
27th Nov 20237:00 amRNSTransaction in Own Shares
24th Nov 20237:00 amRNSTransaction in Own Shares
22nd Nov 20237:00 amRNSTransaction in Own Shares
8th Nov 20237:00 amRNSCapacity Value Update
7th Nov 202312:43 pmRNSNotification of Major Holdings
7th Nov 202312:38 pmRNSTransaction in Own Shares
7th Nov 20237:00 amRNSTransaction in Own Shares
6th Nov 20237:00 amRNSTransaction in Own Shares
1st Nov 20237:00 amRNSTotal Voting Rights
27th Oct 20237:00 amRNSTransaction in Own Shares
12th Oct 20237:00 amRNSTransaction in Own Shares
10th Oct 20237:00 amRNSDividend Policy & Share Repurchase Programme
4th Oct 202310:50 amRNSNotification of Major Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.